Mutant gene-targeted immunotherapy approach developed
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer
Read more
Response to gene-targeted drugs depends on cancer type
Cancers with the same genetic weaknesses respond differently to targeted drugs depending on the tumour type of the patient, new
Read more